ARTICLE | Clinical News

Myoview kit for technetium-labeled tetrofosmin regulatory update

March 6, 2000 8:00 AM UTC

NAM's Nycomed Amersham Imaging unit (Princeton, N.J.) received an approvable letter from the FDA for the expanded use of Myoview with pharmacologic stress agents to diagnose coronary artery disease in patients unable to exercise. The product is approved for cardiac perfusion imaging. ...